Main Menu

Target Evaluation & Molecular Therapeutics Team

Dr Olivia Rossanese’s team is investigating new targets to support the discovery of novel therapeutics to treat cancer. The team is also defining the molecular and genetic factors governing a cancer’s sensitivity to treatment with new drugs, to guide their clinical use.

Team leader

Dr Olivia  Rossanese

Dr Olivia Rossanese

Dr Olivia Rossanese is Head of Biology in the Cancer Research UK Cancer Therapeutics Unit within the Division of Cancer Therapeutics. She is investigating new therapeutic targets for the treatment of cancer and examining the molecular consequences of their inhibition in cancer cells and tumours.

Team Members

Paul Eve

Senior Scientific Officer

Dr Mike Walton

Post-doctoral Scientist

Emily Wholey

Scientific Officer
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.